Ab­b­Vie nabs sev­enth FDA ap­proval for Rin­voq, adds Crohn’s dis­ease in­di­ca­tion

Ab­b­Vie picked up an­oth­er in­di­ca­tion for block­buster Rin­voq on Thurs­day, this time for Crohn’s dis­ease. The sev­enth FDA ap­proval for the JAK in­hibitor is specif­i­cal­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER